NCT03229824View on ClinicalTrials.gov

Use of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

October 3, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

May 30, 2018

Conditions
Breast Cancer
Interventions
DEVICE

Antiseptic occlusive dressing group

A chlorhexidine gluconate occlusive adhesive dressing (Tegaderm CHG) will be applied to the intervention drain sites and changed every seven days.

Trial Locations (1)

14080

Instituto Nacional de Cancerología, Mexico City

All Listed Sponsors
collaborator

Instituto Nacional de Rehabilitacion

OTHER_GOV

lead

National Institute of Cancerología

OTHER_GOV

NCT03229824 - Use of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical Trial | Biotech Hunter | Biotech Hunter